Home Indexes Ideas and Research Alerts Portfolios My tickerspy newswire
QQQQ: 43.27 +1.41% | SPY: 107.59 +1.61%
Discuss Index Tracked By  


  Track the *RXCAN Index  

Cancer Stocks (*RXCAN)


  Today: +1.1%
1-month: -6.6%
All-time: -8.3%
Today vs S&P 500 : -0.5%
1-month vs S&P 500: -0.5%
All-time vs S&P 500: +15.4%
Cancer Stocks
Data since: Jan-01-2008 | Index created by tickerspy
105 members Tracking
  Index Description:

These medical firms have significant exposure to cancer detection and treatment

       

Index Performance



Index Stats
Avg. Market Cap:$1.4B
Avg. P/E Ratio:10.8
Avg. Div Yield:0.0%
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  % off
52wk lw
% from
52wk hg
Alerts
 AEZS $0.82 0.00 -0.2% 42,154 15% $43.6M 36% -75% No Alerts/News
 ALTH $6.91 +0.04 +0.6% 250,390 21% $714.0M 29% -21% 1 Alert (0 News) - View
 ANX $0.30 +0.01 +3.2% 4,225,537 17% $26.6M 329% -41% 1 Alert (0 News) - View
 ARIA $2.29 +0.06 +2.5% 1,302,773 126% $242.6M 136% -34% No Alerts/News
 ARRY $2.37 -0.04 -1.7% 140,934 39% $118.8M 41% -49% No Alerts/News
 BCRX $6.43 -0.12 -1.8% 403,321 43% $287.1M 459% -52% 2 Alerts (1 News) - View
 CEPH $65.83 +0.83 +1.3% 1,075,287 77% $4.8B 25% -18% 1 Alert (0 News) - View
 CYTK $3.05 -0.01 -0.3% 52,312 22% $163.9M 120% -45% No Alerts/News
 DNDN $29.33 +0.44 +1.5% 862,192 51% $3.3B 1050% -5% 2 Alerts (1 News) - View
 ENZN $9.00 0.00 0.0% 531,728 125% $408.5M 91% -22% 1 Alert (1 News) - View
 EXEL $6.33 +0.23 +3.8% 372,744 68% $654.7M 55% -21% No Alerts/News
 GERN $5.42 -0.01 -0.2% 627,933 44% $494.4M 48% -41% 2 Alerts (1 News) - View
 GNBT $0.59 -0.01 -1.5% 777,306 32% $147.8M 633% -49% 1 Alert (0 News) - View
 GTXI $4.15 +0.03 +0.7% 41,531 18% $150.0M 29% -69% 1 Alert (0 News) - View
 HGSI $26.86 +1.10 +4.3% 2,658,574 110% $4.6B 5869% -16% 1 Alert (0 News) - View
 HSP $49.68 +0.92 +1.9% 486,366 71% $7.8B 134% -6% 1 Alert (0 News) - View
 ISIS $11.10 +0.10 +0.9% 341,807 43% $1.0B 14% -41% No Alerts/News
 KERX $2.33 +0.06 +2.6% 513,370 38% $108.5M 2489% -32% 1 Alert (0 News) - View
 MSHL $0.55 -0.03 -5.2% 68,290 190% $42.6M 120% -68% 2 Alerts (1 News) - View
 MYGN $21.45 -0.22 -1.0% 1,631,894 122% $2.0B -1% -54% 1 Alert (0 News) - View
 ONXX $29.08 +0.62 +2.2% 415,369 80% $1.7B 33% -21% No Alerts/News
 OSIP $34.27 +0.10 +0.3% 281,956 45% $1.9B 27% -19% 1 Alert (1 News) - View
 PDLI $6.63 +0.08 +1.2% 954,600 62% $782.5M 27% -29% No Alerts/News
 PGNX $4.45 -0.02 -0.5% 17,251 20% $141.5M 26% -51% No Alerts/News
 PPHM $3.10 -0.03 -0.9% 90,711 41% $741.6M 103% -45% No Alerts/News
 QLTI $4.52 +0.01 +0.2% 36,294 20% $246.3M 223% -12% 2 Alerts (1 News) - View
 REGN $26.31 +0.54 +2.1% 272,576 59% $2.0B 123% -8% No Alerts/News
 SGEN $9.53 +0.19 +2.0% 305,647 71% $938.9M 36% -36% No Alerts/News
 TELK $0.91 0.00 0.0% 68,520 26% $48.5M 237% -35% No Alerts/News
 UTHR $58.32 +1.03 +1.8% 369,254 58% $3.0B 113% -6% No Alerts/News
 VRTX $38.05 +0.63 +1.7% 749,808 54% $7.1B 47% -14% No Alerts/News
 XOMA $0.42 -0.01 -2.3% 2,629,072 73% $61.2M 14% -69% 1 Alert (0 News) - View
 ZGEN $5.10 -0.02 -0.4% 68,913 20% $353.4M 63% -30% No Alerts/News
Discuss the Cancer Stocks (*RXCAN)
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
All Eyes on Dendreon Corp.
DNDN  
Linked by WallStNation.com ( track newsfeed | ignore newsfeed ) - February 09, 11:43AM from (wallstnation.com)
Dendreon Corporation (NASDAQ:DNDN) could have an instant $1 billion in sales if the FDA votes to approve the company's cancer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow
ENZN  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - February 09, 10:06AM from (www.businesswire.com)
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced today that it will report its financial results for the quarter ended  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
OSI Pharmaceuticals to Announce Fourth Quarter and Year-End 2009 Financial Results on February 23, 2010
OSIP  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - February 09, 10:00AM from (www.businesswire.com)
OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its fourth quarter and year-end 2009 financial results will  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cash Rich, No Debt Stocks
QLTI  BIIB  CHL  LTON  FACT  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - February 08, 01:58PM from (stocks.investopedia.com)
Anytime you can find a company with lots of cash and little or no debt, it's worth a closer look.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Traders Send Select Stem Cell Shares Soaring
OPXA  JNJ  ABT  NBS  GILD  PSTI  BCRX  NVAX  ATHX  GERN  OSIR  CUR  
Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - February 08, 10:30AM from (www.tickerspy.com)
The absence of notable news didn't stop speculators in the stem cell sector on Monday.


Select stem cell  more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Marshall Edwards, Inc. Announces Resignation of Christopher Naughton From Board of Directors
NVGN  MSHL  NRT  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - February 08, 08:00AM from (www2.marketwire.com)
Marshall Edwards, Inc. (NASDAQ: MSHL) announced that Christopher Naughton had resigned as a member of the Board of Directors  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vertex Pharmaceuticals Reports 2009 Financial Results and Highlights Recent Progress in Hepatitis C and Cystic Fibrosis Development Programs
VRTX  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - February 04, 04:04PM from (www.businesswire.com)
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today provided an update on recent progress in its late-stage development  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
BCRX  APT  RHHBY  NVAX  INO  GNBT  SVA  NVS  SNY  
Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - February 04, 10:35AM from (www.tickerspy.com)
While select swine flu players have seen their pops and drops, BioCryst Pharmaceuticals (BCRX) may have emerged as the small-cap champion of the 2009 pandemic.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Hospira Reports Fourth-Quarter and Full-Year 2009 Results
HSP  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - February 04, 07:27AM

LAKE FOREST, Ill., Feb. 4 /PRNewswire-FirstCall/ -- Hospira,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ZymoGenetics to Host Conference Call and Webcast on February 11, 2010 to Discuss 2009 Year-end Financial Results
ZGEN  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - February 04, 06:00AM from (www.businesswire.com)
ZymoGenetics, Inc. (NASDAQ:ZGEN) announced today that it will report fourth quarter and year-end 2009 financial results on  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2009 Financial Results
CYTK  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - February 03, 04:00PM from (www2.marketwire.com)
Cytokinetics, Incorporated (NASDAQ: CYTK) reported revenues from research and development collaborations of $1.0 million  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Onyx Pharma initiated with "buy"
ONXX  
Linked by newratings ( track newsfeed | ignore newsfeed ) - February 03, 01:43PM from (www.newratings.com)
NEW YORK, February 3 (newratings.com) - Analysts at Brean Murray initiate coverage of Onyx Pharma (ticker: ONXX) with a "buy"  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And mondoBIOTECH holding AG Announce Today a Global Strategic Partnership Agreement for the Development Of Aviptadil Platform
UTHR  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - February 03, 01:34PM from (www.businesswire.com)
United Therapeutics Corporation (NASDAQ: UTHR), und mondoBIOTECH holding AG (SIX: RARE) melden globale strategische Partnerschaft  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Home Diagnostics Buyout Powers Diabetes Segment
NVO  AMLN  HDIX  MNKD  GNBT  ARRY  
Linked by tickerspy blog ( track newsfeed | ignore newsfeed ) - February 03, 12:03PM from (www.tickerspy.com)
Home Diagnositics (HDIX) is soaring today after the company announced a definitive merger agreement with Nipro Corporation.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35) for Front-line Hodgkin Lymphoma
SGEN  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - February 03, 09:00AM from (www.businesswire.com)
Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 65



 

 

 

 

 

 

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
Index components are equally weighted.
Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Cancer Stocks Index (*RXCAN).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments